Document is current
Any future updates will be listed below
-
Authors
Shen, Che-Hung http://orcid.org/0000-0002-1309-6190
Hsieh, Chi-Che
Jiang, Kuan-Ying
Lin, Chih-Yu
Chiang, Nai-Jung
Li, Ting-Wei
Yen, Chun-Ting
Chen, Wan-Ju
Hwang, Daw-Yang
Chen, Li-Tzong
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (107-2314-B-400-036-MY3)
Kaohsiung Medical University (KMU-TC109A04-0)
- License Information
-
More Information
Article History
Received: 25 February 2021
Accepted: 16 July 2021
First Online: 23 July 2021
Declarations
:
: Patients with GISTs who failed to respond to imatinib and sunitinib therapy (NCT0139583) was conducted in several Taiwan Cooperative Oncology Group (TCOG)-affiliated medical centers between October 2011 and January 2015. All patients gave signed informed consent. Mice were maintained in accordance with facility guidelines on animal welfare and with protocols approved by the Institutional Animal Care and Usage Committee (IACUC) of the National Health Research Institutes (NHRI, Taiwan).
: Informed consent was obtained from all individual participants included in the study. The authors affirm that human research participants provided informed consent for publication of the data in this article.
: The authors have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript.
